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Background and objectives: Clinical responsiveness to cognitive behavioural therapy for psychosis (CBTp)
varies. Recent research has demonstrated that illness perceptions predict active engagement in therapy, and,
thereby, better outcomes. In this study, we aimed to investigate the psychometric properties of a modiﬁ-
cation of the Illness Perceptions Questionnaire (M-IPQ) designed to predict response following CBTp.
Methods: Fifty-six participants with persistent, distressing delusions completed the M-IPQ; forty before
a brief CBT intervention targeting persecutory ideation and sixteen before and after a control condition.
Additional predictors of outcome (delusional conviction, symptom severity and belief inﬂexibility) were
assessed at baseline. Outcomes were assessed at baseline and at follow-up four to eight weeks later.
Results: The M-IPQ comprised two factors measuring problem duration and therapy-speciﬁc perceptions of
Cure/Control. Associated subscales, formed by summing the relevant items for each factor, were reliable in
their structure. The Cure/Control subscale was also reliable over time; showed convergent validity with
other predictors of outcome; predicted therapy outcomes; and differentially predicted treatment effects.
Limitations: We measured outcome without an associated measure of engagement, in a small sample.
Findings are consistent with hypothesis and existing research, but require replication in a larger, pur-
posively recruited sample.
Conclusions: The Cure/Control subscale of the M-IPQ shows promise as a predictor of response to
therapy. Speciﬁcally targeting these illness perceptions in the early stages of cognitive behavioural
therapy may improve engagement and, consequently, outcomes.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Cognitive behavioural therapy for people with psychosis (CBTp)
is effective in reducing symptoms, but effect sizes are modest, andfax: þ44 020 7848 5006.
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r Ltd. This is an open access articleindividual outcomes are heterogeneous (National Institute of
Health and Care Excellence (NICE), 2009, 2014). The degree of
engagement in therapy also varies: approximately half of those
offered therapy in routine services will refuse (Prytys, Garety, Jolley,
Onwumere, & Craig, 2011), and, even in research studies, although
dropout rates may be low (Villeneuve, Potvin, Leasage, & Nicole,
2010), only a proportion of those accepting therapy are likely to
engage in the full range of therapy techniques offered (Dunn et al.,
2012). In the Prevention of Relapse in Psychosis trial (PRP, Garety
et al., 2008), fewer than half (41%) of those allocated to the CBT
arm of the trial received ‘full’ therapy (i.e. including active CBT
strategies). While full therapy was associated with signiﬁcantunder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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of psychotic and affective symptoms), those receiving a more limited
range of interventions (‘partial’ therapy; primarily engagement and
assessment work) showed a small deterioration, although this did
not reach statistical signiﬁcance (Dunn et al., 2012).
The predictors of engagement reported by Dunn et al. (2012)
were primarily demographic. However, Freeman, Dunn, Garety,
et al. (2013) later demonstrated that engagement in full therapy,
and thereby response to CBTp, was predicted by particular beliefs
held by the individual about their difﬁculties. Compared to those
receiving partial therapy or ‘no therapy’ (i.e. non-attenders or early
drop-out), those engaging in full therapy tended to endorse more
internal, psychological causes of their presenting problems, ex-
pected their problems to last longer, and believed that the prob-
lem could be cured or controlled (Freeman, Dunn, Garety, et al.,
2013).
These secondary appraisals of the nature, meaning and man-
agement of the problem were assessed in the PRP trial using the
Illness Perceptions Questionnaire (IPQ, Weinman, Petrie, Moss-
Morris, & Horne, 1996). The IPQ was originally developed to
measure patients' beliefs about their physical health problems, in
order to improve understanding of their responses to illness and
their adherence to a range of healthcare interventions. It draws on
the ‘cognitive representation’ of illness speciﬁed in Leventhal's
self-regulatory model, comprising beliefs in ﬁve interrelated do-
mains: i) the identity and nature of the illness; ii) the cause of the
illness; iii) the likely duration of the illness; iv) the consequences of
the illness (i.e. expected effects or impact); and v) whether and
how the illness can be cured or managed. Beliefs about cure and
control include appraisals of the available treatments, their likely
impact, and the extent to which one's own efforts at management
are likely to be effective. Following a perceived health threat, the
cognitive representation of illness determines the individual's
practical and emotional responses. These are manifested as
adjustment and coping behaviours, and include engagement with
and adherence to the recommended treatment regimen, such as
medication, rehabilitation, or psychotherapy (Broadbent, Petrie,
Main, & Weinman, 2006; Leventhal, Nerenz, & Steele, 1984;
Moss-Morris et al., 2002). The IPQ has good psychometric prop-
erties, and a growing body of research supports the inﬂuence of
illness perceptions upon recovery across a broad spectrum of
physical health problems (e.g. Petrie, Jago, & Devcich, 2007; Petrie
& Weinman, 2006; Sirri, Fava, & Sonino, 2013; Stewart & Yuen,
2011). Moreover, in trials of psychoeducational and motivational
interventions designed to promote engagement in recommended
treatments, illness perceptions have been demonstrated to
mediate changes in treatment adherence and outcome (e.g.
Broadbent, Ellis, Thomas, Gamble, & Petrie, 2009; Chilcot & Moss-
Morris, 2013; Foster et al., 2008; Goodman, Firouzi, Banya, Lau-
Walker, & Cowie, 2013; Juergens, Seekatz, Moosdorf, Petrie, &
Rief, 2010; Kucukarslan, 2012; Petrie, Cameron, Ellis, Buick, &
Weinman, 2002; Petrie, Weinman, Sharpe, & Buckley, 1996; Rose
et al., 2012; Sharloo et al., 2010, 2007).
Similar associations of illness perceptions with adjustment, re-
covery and engagement with services have been reported for
people with mental health problems, including psychosis (Baines&
Wittkowski, 2013; Broadbent, Kydd, Sanders, & Vanderpyl, 2008;
Lobban, Barrowclough, & Jones, 2003, 2004, 2005; Løvvik,
Overland, Hysing, Broadbent, & Reme, 2013; Watson et al., 2006;
Williams & Steer, 2011). As in the physical health research, the
focus of these studies has been engagement with recommended
treatment in the broad sense of a care regimen, rather than with
talking therapies speciﬁcally. However, factors shown to predict
uptake of talking therapies such as expectations of change; self-
efﬁcacy; and the degree of ‘ﬁt’ between the person's causal modeland the therapy offered (e.g. Dozois, Westra, Collins, Fung, & Garry,
2004; Gearing, Townsend, Elkins, El-Bassel, & Osterberg, 2014;
Heins, Knoop, & Bleijenberg, 2013; Lewin, Peris, Bergman,
McCracken, & Piacentini, 2011; Trockel, Karlin, Barr Taylor, &
Manber, 2014) link plausibly with the timeline, cure/control, and
cause components of the IPQ that were found to predict therapy
uptake in the PRP trial.
Being able to predict engagement in and response to therapy in
routine care is an important goal, with the potential both to
improve the efﬁciency of services and to facilitate the development
of alternative approaches tailored to suit those who ﬁnd CBTp
unacceptable or unhelpful. Our aim in this study was to pilot a
modiﬁcation of the IPQ, designed speciﬁcally to predict response
following cognitive behavioural therapy in people with psychosis.
Thus, in the ﬁrst part of the study we examined the psychometric
properties of the measure: internal consistency, factor structure,
testeretest reliability, and the extent to which the questionnaire
correlated with known predictors of outcome. The second part of
the study was a prospective investigation of the ability of the
modiﬁed measure to: i) predict clinical outcome in participants
receiving a brief cognitive behavioural intervention, and ii) to
differentially predict response for an intervention group compared
to a no-intervention control group.
2. Material and methods
2.1. Participants
Participants were recruited from the last cohort of the Cognitive
Mechanisms of Change in Delusions study (ISRCTN 59501939),
carried out by the Psychosis Research Partnership. Therapy par-
ticipants completed a brief, targeted intervention for delusions,
with a focus on persecutory content (Freeman et al., 2014; Waller,
Freeman, Jolley, Dunn, & Garety, 2011). Recruitment for the cur-
rent study took place over 18 months, from July 2010 to January
2012, in community adult mental health services in NHS trusts in
the South East and East of England. Inclusion criteria for individual
participants were: i) a current delusion, assessed using the
Schedules for Clinical Assessment in Neuropsychiatry (SCAN,World
Health Organisation (WHO), 1992a, 1992b), and rated as distressing
(>0) on a visual analogue scale; ii) a diagnosis of a schizophrenia
spectrum psychosis (ICD-10, F20-29, WHO, 1992a, 1992b) which
was veriﬁed by SCAN interview; iii) aged 18e65 at study entry; and
iv) a sufﬁcient grasp of English to complete measures and partici-
pate in the intervention. In order to recruit a group with persistent,
stable delusions, self-rated delusional conviction had to have
consistently reached a minimum of 50%, with no major psychotic
relapses or crises, over the preceding three months. Exclusion
criteria were: a primary diagnosis of alcohol or drug dependency;
an organic syndrome; or a learning disability.
2.2. Measures
Demographic and clinical data (age, gender, ethnicity and length
of illness in years) were self-reported by participants and corrob-
orated by the clinical record.
2.2.1. Modiﬁed Illness Perceptions Questionnaire (M-IPQ, after
Weinman et al., 1996)
The modiﬁed measure comprised 14 items (Table 2). Eleven
were those found to predict engagement by Freeman and col-
leagues, drawn from the original IPQ (Weinman et al., 1996).
Wording for these items had been modiﬁed for use with people
with psychosis to ‘problems/illness’ rather than ‘illness’ to accom-
modate respondents who did not consider themselves to have an
E. Marcus et al. / J. Behav. Ther. & Exp. Psychiat. 45 (2014) 459e466 461illness (Jolley & Garety, 2004; Watson et al., 2006). To these we
added three new items, drawn from the talking therapies outcome
literature, and designed to measure expectations of change and the
extent to which a cognitive behavioural approach ﬁtted with the
person's own ideas about what would help with their problems. For
the current study, the item ‘My treatment will be effective in curing
my current problems/illness’ was changed to ‘Talking therapy will
be effective in improving my current problems/illness’. Each item
was rated on a ﬁve- point Likert scale in opinion format, ranging
from Strongly Disagree to Strongly Agree. Higher scores represented
increasing likelihood of engagement (i.e. higher levels of cure-
control, greater optimism and expectation of change, longer
perceived timeline, and stronger endorsement of psychological
causes and the relevance of cognitive therapy ideas). The original
IPQ has good psychometric properties; the psychometric properties
of the modiﬁed measure were to be assessed.
2.2.2. Clinical outcome
Persecutory ideation was measured using a brief scale of ﬁve
visual analogue ratings, taken from Green et al.'s (2008) Paranoid
Thought Scales, assessing ideas of persecution and reference. Items
were selected for high loadings on their respective subscales, and to
ensure coverage of a range of aspects of paranoia. Items were: I am
being deliberately harmed or upset; I am being followed; There
is a conspiracy against me; I am being persecuted; I am being
laughed at behind my back. Each item was rated from 0 (not at all)
to 100% (totally), with higher scores indicating a greater level of
persecutory ideation, and the mean of all ﬁve scales forming an
overall paranoia score. The scale has good internal reliability
(Cronbach's alpha ¼ 0.86; Freeman, Dunn, Fowler, et al., 2013; 0.82
for the current, overlapping, sample).
2.2.3. Predictors of outcome
Greater symptom severity at baseline, higher levels of convic-
tion, and belief inﬂexibility, although not speciﬁcally demonstrated
tomoderate treatment effects, have all been associated with poorer
outcomes in trials of CBTp (Brabban, Tai, & Turkington, 2009;
Garety et al., 1997; Naeem, Kingdon, & Turkington, 2008). For the
current study, participants provided personalised ratings of their
degree of conviction in their delusion, indicating how much they
believed it from 0 (not at all) to 100 (totally). Belief inﬂexibility
(Garety et al., 2005; So et al., 2012) was measured by reverse
scoring ratings of the extent to which participants considered it
possible they were mistaken in their delusion, rated from 0 (not at
all) 100% (totally) (Waller et al., 2011).
2.3. Procedure
Participants in the current study completed theM-IPQ and other
measures as part of a larger, repeated, assessment battery designed
to evaluate change during brief cognitive behavioural in-
terventions. They were participating in one of two randomised
controlled trials (RCTs, randomising participants to brief interven-
tion or a no-therapy control condition in a 2:1 or 1:1 ratio,
depending on the trial) or in a case series. All the measures for the
current study were completed at baseline by all participants. Con-
trol participants completed the M-IPQ at baseline (Time 1) and at a
second time point two to eight weeks later (Time 2). Intervention
participants completed the clinical outcome measure (paranoia
scale) at baseline and at follow-up, four to eight weeks later.
Measures were administered by trained research workers. Partici-
pants provided informed consent under protocols approved by the
appropriate ethics and local research and development committees
(London Wandsworth Research Ethics Committee 07/H0803/140),and received recompense for their time spent taking part in
the study.
2.4. Analyses
Data were analysed using SPSS version 20 (IBM, 2011). The as-
sociation of M-IPQ scores with baseline demographic and clinical
characteristics (age, gender, ethnicity, length of illness) was
examined in the full sample using correlational analysis and one-
way ANOVA. Baseline M-IPQ scores for the full sample were sub-
jected to a principal components analysis with an oblique rotation
(direct oblimin), as the factors were not expected to be fully
orthogonal. Subscales were formed by summing the items loading
on each factor. Inter-item correlations and internal consistency
(Cronbach's a) were calculated for the full scale and for each sub-
scale. Testeretest reliability was calculated by comparing baseline
to follow-up scores for control participants only, using intraclass
correlations. The relationship of the M-IPQ to other known pre-
dictors of outcome (baseline symptom severity, belief inﬂexibility,
and conviction) was assessed in the full sample by Pearson corre-
lations. Associations of the M-IPQ with clinical outcome following
therapy, were assessed for the therapy group only, using linear
regression analysis, with paranoia score at follow-up as the
dependent variable, and the M-IPQ subscales as predictors, con-
trolling for baseline paranoia in the ﬁrst block, and, in the second
block, for other predictors of outcome, in order to assess the ability
of the M-IPQ to predict outcome over and above known predictors
(i.e. those identiﬁed by previous literature). The ability of theM-IPQ
to predict response to therapy was assessed in a second series of
regression analyses including all participants, both control and
therapy. A separate analysis was conducted for eachM-IPQ subscale
associated with outcome. Paranoia score at follow-up was the
dependent variable in each analysis; the key independent variable
was an interaction term of the selected M-IPQ subscale  therapy
allocation. Analyses controlled for baseline paranoia, the other
three outcome predictors, the selected M-IPQ subscale and therapy
allocation. A backwards selection procedure was employed. The
analysis was repeated, excluding the case series participants, as
these had not been randomly allocated to treatment condition.
There was a single missing item for one participant on the M-IPQ,
which was replaced by the mean (of the remaining items) for the
factor analysis. Participants with missing data were otherwise
excluded and sample sizes reported.
3. Results
3.1. Participants
A total of 56 people with schizophrenia spectrum psychosis
completed the M-IPQ and therefore participated in the study. All
participants had a current, stable, distressing and strongly held
delusion. Forty participants completed the brief intervention,
either as part of a larger RCT (n¼ 34) or a case series (n¼ 6). Sixteen
participants were in the no-therapy control group. The sample was
mainly male, and of mixed ethnicity, with schizophrenia being the
most common diagnosis. Demographic and clinical characteristics
are shown in Table 1.
3.2. Reliability and factor structure of the M-IPQ
The internal consistency of the full M-IPQ scale was just
acceptable (Cronbach's a ¼ 0.7), with some collinearity amongst
the items, and multiple inter-item correlations of 0.3 and above,
indicating that the derivation of factors was appropriate. Principal
components analysis, with direct oblimin rotation, resulted in the
Table 1
Demographic and clinical characteristics.
Variable Total (n ¼ 56) Brief therapy (n ¼ 40)
Mean (SD)
Age (years) 42.4 (10.8) 41.0 (10.7)
Length of illness (years) 15.3 (10.3) 13.5 (10.1)
Baseline paranoia 36.4 (28.8) 31.1 (24.3)
Follow-up paranoia 29.3 (27.8, n ¼ 54) 25.9 (27.4, n ¼ 38)
Baseline outcome predictors
conviction
79.5 (26.8, n ¼ 55) 78.0 (28.3, n ¼ 39)
Belief inﬂexibility 77.7 (27.8, n ¼ 53) 76.8 (28.4, n ¼ 38)
Delusion distress 65.4 (32.6, n ¼ 55) 58.2 (22.3, n ¼ 39)
Gender (n)
Male 38 28
Female 18 12
Ethnicity (n)
White-British/Irish/other 30 23
Black-Caribbean/African/
mixed/other
22 16
Asian-mixed/other 4 1
Diagnosis (n) (n ¼ 54) (n ¼ 39)
Schizophrenia 48 35
Paranoid schizophrenia 1 1
Schizoaffective disorder 3 3
Delusional disorder 1 0
Other non-organic psychotic
disorder
1 0
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ﬁrst three principal components, respectively accounted for 39%,
12% and 11% of the variance in M-IPQ scores (62% of the variance
in total).
Two of the three reverse scored items, which were drawn from
the original IPQ (Items 5 and 7), and were designed to tap hope-
lessness and a fatalistic approach to change, did not appear to
correlate as expected. The analysis was repeated with these items
omitted, which reproduced the same structure, with very slightlyTable 2
Item loadings for each factor of the modiﬁed Illness Perceptions Questionnaire (M-IPQ, n
Item
1. My problems can improvea
2. There is a lot which I can do to improve my problems
3. What I do can determine whether my current problems/illness
get better or worse
4. My current problems/illness will improve in time
5. There is very little that can be done to improve my current
problems (R)
6. Talking therapy will be effective in improving my current
problems/illnessb
7. Recovery from my current problems is largely dependent
on fate or chance (R)
8. My current problems/illness will last a short time (R)
9. My current problems/illness are likely to be permanent
rather than temporary
10. My current problems/illness will last for a long time
11. My state of mind played a major part in causing my current
problems/illness
12. Something about my personality played a role in causing
my current problems/illness
13. Changing the way I think or the way I do things can improve
my problemsa
14. Looking at things differently can be helpfula
Key: coefﬁcients < 0.3 are suppressed; bold text denotes item considered part of this fa
efﬁcients remain constant.
a New items assessing expectation of change (Item 1) and Cognitive model ﬁt (Items
b Item wording modiﬁed to ‘Talking therapy’ rather than ‘Treatment’.altered item loadings. The three components and both sets of item
loadings are shown in Table 2, and were labelled Cure/Controlþ,
Timeline and Internal/External Causality.
M-IPQ subscale scores were calculated by simply adding the
relevant items (allowing for sign reversals, where relevant). The
Cure/Controlþ subscale comprised seven items (Items 1, 2, 3, 4, 6,
13, 14) which assessed the extent to which the individual perceived
themselves to be able to control and change their current problems
(e.g. ‘There is a lot which I can do to improve my problems’). The new
items assessing expectations of change, and those assessing CBT ﬁt
loaded on the Cure/Control factor, and the subscale showed good
internal reliability (Cronbach's a ¼ 0.9) and high inter-item corre-
lations, suggesting that it is tapping a broader Cure/Control
construct, incorporating speciﬁc beliefs about therapy. The Time-
line subscale comprised three items from the original IPQ (Items 8,
9, 10) which assessed the individual's perceived duration of their
problems/illness (e.g. ‘My current problems/illness will last a long
time’). Internal reliability was just acceptable (Cronbach's a ¼ 0.7).
Two items (Items 11 and 12) which measured the extent to which
the person considered their problems/illness to be internally
caused (e.g. ‘My state of mind played a major part in causing my
current problems/illness’) loaded on the Internal/External Causality
factor, together with the two reverse scored items (Items 5 and 7)
designed to access hopelessness and fatalism about change (in
contrast to self-efﬁcacy). Internal reliability across these items was
unacceptably low, and all inter-item correlations were below 0.2.
For subsequent analyses, therefore, items 5 and 7 were omitted,
and the two internal causality items were examined individually.
Inter-item correlations are shown in Table 3; M-IPQ subscale mean
scores are given in Table 4.
3.3. Testeretest reliability
Testeretest reliability was calculated for the control group
participants only and was good for the Cure/Controlþ subscale
(r ¼ 0.9, p < 0.001, n ¼ 15), but questionable for the Timeline
subscale (r ¼ 0.6, p < 0.001, n ¼ 15). The internal causality items
showed an unacceptable testeretest reliability (State of Mind:¼ 56).
Factor 1
Cure/control
Factor 2
Timeline
Factor 3
Causes
0.8
0.9
0.7 (0.8)
0.7 0.3
0.4 0.5
0.6 (0.7)
0.8
0.7
0.8 (0.9)
0.8
0.6 ¡0.5 (0.4)
¡0.5 (0.9)
0.8
0.8
ctor; () ¼ coefﬁcient if different once items 5 and 7 are removed; if not noted, co-
13 and 14).
Table 3
Inter-item correlations for the modiﬁed Illness Perceptions Questionnaire (M-IPQ, n ¼ 56).
Item 1 2 3 4 6 13 14 8 9 10 11 12 5 7
Cure/controlþ 1 e 0.7 0.5 0.6 0.3 0.5 0.6 0.4 0.4
2 0.7 e 0.5 0.7 0.5 0.7 0.7 0.3 0.4 0.4
3 0.5 0.5 e 0.6 0.5 0.5 0.5 0.3 0.3
4 0.6 0.7 0.6 e 0.5 0.6 0.7 0.5 0.4 0.3 0.3
6 0.3 0.5 0.5 0.5 e 0.5 0.6 0.4 0.3 0.3 0.3
13 0.5 0.7 0.5 0.6 0.5 e 0.6 0.4 0.3
14 0.6 0.7 0.5 0.7 0.6 0.6 e 0.3 0.4 0.4 0.4
Timeline 8 0.3 0.5 0.4 0.3 e 0.3 0.5 0.3
9 0.3 0.3 e 0.6
10 0.3 0.4 0.3 0.4 0.5 0.6 e
Internal/external cause 11 0.4 0.4 0.3 0.3 0.3 0.4 0.4 0.3 e 0.3
12 e
5 0.4 0.4 0.3 0.3 0.3 0.4 e 0.3
7 0.3 0.3 e
Correlations < 0.3 are suppressed.
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M-IPQ subscale scores at Time 1 and Time 2 are shown in Table 4.3.4. Demographic and clinical characteristics and the M-IPQ
There were few signiﬁcant associations between M-IPQ scores
and demographic or clinical characteristics. The M-IPQ was un-
related to age, or recruitment centre, but Cure/Controlþ scores
were associated with length of illness (r ¼ 0.3, p ¼ 0.03), such that
a longer duration of illness was associated with greater percep-
tions of control, and the Personality item was associated with
Ethnicity (F(2,53) ¼ 8.8, p < 0.001) and Gender (F(1,54) ¼ 4.5,
p < 0.05), such that male participants and those identifying
themselves as from a White ethnic group were more likely to
endorse internal causes. No other associations with demographic
variables reached signiﬁcance (r values < 0.25, p values > 0.05; F
values all < 3, p values > 0.05).3.5. Convergent validity
Baseline symptom severity and belief inﬂexibility scores are
shown in Table 1. Associations of predictors of outcome with de-
mographic variables were examined; the only association that was
also found for the M-IPQ was with gender, such that male partici-
pants were more likely to be ﬂexible in their beliefs (F(1,51) ¼ 6.1,
p ¼ 0.02). The Cure/Controlþ subscale was correlated signiﬁcantly
or at a trend level with all other outcome predictors except baseline
paranoia (distress r¼0.3, p < 0.05; conviction: r¼0.3, p¼ 0.06;
belief inﬂexibility: r ¼ 0.3, p ¼ 0.02). Of the other M-IPQ com-
ponents, only Personality showed a trend association with
conviction (r ¼ 0.2, p ¼ 0.07); otherwise associations were insig-
niﬁcant (r values < 0.2, p values > 0.2). Controlling for gender didTable 4
Mean modiﬁed Illness Perceptions Questionnaire (M-IPQ) subscale scores at baseline an
following therapy for each subscale.
Subscale/item Total baseline (n ¼ 56) Control T1 (n ¼ 15a) Control T2
Mean (SD)
Cure/controlþ 26.1 (6.2) 25.6 (6.0) 24.3 (6.2)
Timeline 10.1 (2.9) 11.5 (2.3) 11.6 (2.4)
State of mind 3.5 (1.3) 3.9 (1.1) 3.9 (1.0)
Personality 3.3 (1.2) 3.3 (1.1) 3.4 (1.0)
a One control participant did not complete post measures.
b Therapy group only, 6 participants with missing data on one or more variables.
c F(8,26) ¼ 3.3, p ¼ 0.01; r ¼ 0.7, R2 ¼ 0.35; controlling for baseline paranoia and then fnot alter the lack of association between belief inﬂexibility and
Personality.
3.6. Prediction of clinical change scores following therapy
Mean paranoia scores at baseline and follow-up for the therapy
group are shown in Table 1. Therapy outcomes were not signiﬁ-
cantly related to demographic variables (F values< 3; r values 0.2,
p values > 0.05). Linear regression analysis showed signiﬁcant
associations of the Cure/Controlþ subscale at baseline with
paranoia outcomes following therapy, controlling for baseline
paranoia. The overall model was signiﬁcant and accounted for
35% of the variance in clinical outcome. Cure/Controlþ remained
a signiﬁcant predictor irrespective of controlling for other pre-
dictors of outcome (baseline distress, conviction and belief
inﬂexibility; Table 4). Only Cure/Controlþ of the M-IPQ subscales
was therefore entered into the second series of regression ana-
lyses, including all participants. The ﬁnal model accounted for
46% of the variance in paranoia outcomes at follow-up, with a
signiﬁcant contribution from the Cure/Control  therapy alloca-
tion interaction (b ¼ 1.0, p ¼ 0.04), controlling for allocation
(b ¼ 1.0, p ¼ 0.04), Cure/Controlþ (b ¼ 0.6, p ¼ 0.004), and
baseline paranoia (b ¼ 0.6, p < 0.001). Excluding the case series
participants resulted in an almost identical model (45% of the
variance accounted for; Cure/Control  therapy allocation inter-
action (b ¼ 1.2, p ¼ 0.03), controlling for allocation (b ¼ 1.0,
p ¼ 0.04), Cure/Controlþ (b ¼ 0.6, p ¼ 0.004), and baseline
paranoia (b ¼ 0.6, p < 0.001)).
4. Discussion
We conducted a pilot validation of a modiﬁed version of the
Illness Perceptions Questionnaire (M-IPQ), designed to predictd testeretest, with regression results showing the prediction of clinical outcomes
(n ¼ 15a) Therapy baseline (n ¼ 40) Prediction of outcome (n ¼ 34b)
b (p)c
26.1 (6.3) 0.4 (0.03)
9.7 (3.0) 0.3 (0.1)
3.3 (1.4) 0.2 (0.2)
3.3 (1.3) 0.1 (0.4)
or other predictors of outcome (baseline conviction, belief inﬂexibility and distress).
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psychosis (CBTp). We shortened the IPQ to include only those
items predicting therapy uptake (Freeman, Dunn, Garety, et al.,
2013), and added three new items assessing general therapy
engagement. The measure showed acceptable psychometric
properties, and formed three factors, from which two reliable
subscales were derived. The ﬁrst subscale represented an
expanded Cure/Control construct, incorporating new items
measuring hopefulness, self-efﬁcacy, and therapy ﬁt (‘Cure/Con-
trolþ’). The second subscale assessed perceptions of the duration
of the problem (Timeline). The Cure/Controlþ subscale was asso-
ciated with established predictors of outcome, and itself predicted
response to therapy over time.
The factor structure of the modiﬁedmeasure partially replicated
that of the original IPQ. The added items, expectation of change and
therapy ﬁt, did not form separate components, but instead loaded
onto an expanded Cure/Control construct, which had very high
internal and testeretest reliability. Our ﬁndings may indicate that
the Cure/Control concept should be expanded to include ‘hope’ and
‘ﬁt’, which both feature prominently in the literature on engage-
ment and change in psychological therapy and physical health in-
terventions, and have been demonstrated to predict outcome in
CBT (Gearing et al., 2014; Sirri et al., 2013). A clear Timeline factor
was found, replicating previous ﬁndings. The Timeline subscale had
good internal reliability, but questionable reliability over time. In-
ternal causes formed a weak factor, loading with the reverse scored
Cure/Control items assessing a fatalistic attitude to recovery, and
lack of expectation of change. Both internal and testeretest reli-
ability were poor. The reverse scored items were excluded from the
ﬁnal measure, as both the inter-item correlations and factor load-
ings suggested that the meaning and the direction of the items
were misinterpreted by participants. The poor reliability of the
items assessing causes is well-documented, being attributed to the
high potential for idiosyncratic interpretations of the items,
resulting in their exclusion from analyses, or inclusion as separate
items (Lobban et al., 2004; Watson et al., 2006). However, in
common with other studies of illness perceptions in mental health
(Broadbent et al., 2008; Freeman, Dunn, Garety, et al., 2013), we
found a relationship between attribution to internal causes and
Cure/Control, with the State of Mind item loading on the expanded
Cure/Control factor, as well as the weaker Causes factor. The asso-
ciation suggests that internal attributions of cause may be treated
as a component of therapy ﬁt. In this context, re-wording the item
may be useful to ensure it unambiguously captures the therapy-
relevant notion of change in oneself being both possible and
helpful.
The Cure/Control factor showed moderate construct validity,
evidencing small but consistent correlations with measures of
symptom severity, conviction, and belief ﬂexibility, which have all
been demonstrated to predict outcome in previous research. Per-
ceptions of cure control were associated with longer duration of
illness, possibly reﬂecting increasing ability to cope with a stable
presentation over time. We also found that higher perceived levels
of Cure/Control were associated with therapy outcomes. Moreover,
the signiﬁcant association of the Cure/Controlþ  therapy alloca-
tion interaction term with outcomes indicates that the subscale
predicts outcome differentially for the brief CBTp and control
groups. This is important, and supports the future use of the
measure as a potential predictor of response to therapy. However,
neither causal attributions nor timeline predicted outcome in our
sample, contrasting with previous studies (e.g. Freeman, Dunn,
Garety, et al., 2013). The differences may be attributable to char-
acteristics of the presenting problems (e.g. stable or relapsing; early
or longer term) and the intensity and duration of the intervention,
affecting motivation to engage. Systematic investigation of theinﬂuence of these variables on the prediction of engagement and
outcome would be a useful focus of future study.
Participants completed the measure without undue difﬁculty,
and their responses were coherent and meaningful. The ﬁndings
provide further evidence of the clinical utility and feasibility of
measuring illness perceptions in people with psychosis, and, with
small modiﬁcations, the suitability of the IPQ for this group, both
of which have previously been questioned (Kinderman, Setzu,
Lobban, & Salmon, 2006). The high inter-item correlations sup-
port shortening the measure, and this would increase its utility for
routine assessment.4.1. Limitations
As participants were recruited for a speciﬁc research project,
with a particular clinical presentation, and an ethnically diverse
and urban demographic, the generalisability of ﬁndings may be
limited. Future research should aim to clarify the variations in
predictors of engagement and outcome for speciﬁc groups. Sec-
ondly, although response to therapy was measured, engagement
was not, so we can only infer, by associationwith positive outcome,
the extent to which participants engaged with particular inter-
vention strategies. The ability of the M-IPQ to predict engagement
independently of outcome therefore remains untested in this study.
Thirdly, the M-IPQ comprised those items from the original version
of the IPQ that were associated with engagement in the PRP trial.
Content could be improved by drawing on the subsequent modi-
ﬁcations to the IPQ. Fourthly, the M-IPQ and the primary outcome
measure are self-reported. Although M-IPQ items are carefully
phrased to sidestep issues of acknowledging illness, ratings rely on
the person's own perception of their difﬁculties and are potentially
inﬂuenced by poor insight. Finally, as a small pilot validation, the
study is underpowered for a full factor analysis, and for themultiple
associations tested. The control group is particularly small, and
allocation to group was not fully randomised. The ﬁndings regarding
prediction of response to therapy should therefore be treated as
preliminary. Nevertheless, ﬁndings are consistent with the existing
literature and with hypothesised associations.4.2. Implications
This is the ﬁrst study prospectively validating the modiﬁed IPQ
as a predictor of treatment outcome in CBT for psychosis. Our
ﬁndings suggest that perceptions of control and optimism about
change increase the likelihood of a positive outcome following
therapy. Previous research has shown that perceptions of control
also increase the likelihood of engagement in the full range of
therapy techniques (Freeman, Dunn, Garety, et al., 2013), which in
turn mediates positive outcomes (Dunn et al., 2012). In physical
health research, brief interventions focused on modifying illness
perceptions have been successful in increasing engagement in
treatment. It is possible, therefore, that engagement in CBTp could
be increased by a focus on illness perceptions in the early stages of
therapy. Speciﬁcally, modifying illness perceptions to increase
service users' perceptions of the controllability of their difﬁculties
and their expectation of change ought to increase engagement,
with the potential to improve outcomes, and reduce later dropout.
Illness perceptions frameworks have also been used as a means of
training the wider healthcare workforce to communicate in a more
effective, individually tailored and patient-centred manner about
interventions for a range of physical health problems, with positive
impact on outcomes (e.g. Glattacker, Heyduck, & Meffert, 2012). As
clinical communication is a known area of particular difﬁculty in the
treatment of people with psychosis (e.g. McCabe et al., 2013), a
E. Marcus et al. / J. Behav. Ther. & Exp. Psychiat. 45 (2014) 459e466 465similar approach could inform workforce development initiatives to
improve treatment adherence and promote recovery from psychosis.
4.3. Conclusions
Our pilot validation demonstrated the modiﬁed version of the
Illness Perceptions Questionnaire (M-IPQ) to have good psycho-
metric properties. An expanded Cure/Control subscale, incorpo-
rating expectations of change and degree of ﬁt between a CBTp
framework and the service user's own appraisals, was associated
with existing outcome predictors, and predicted outcomes following
therapy. The measure has potential for use as a screening tool in
routine services. Brief interventions speciﬁcally targeting percep-
tions of the controllability of the problem, and the possibility of
change may increase active engagement in CBTp, thereby increasing
the likelihood of a successful outcome.
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